When it comes to having a bad corporate reputation, it doesn’t get much worse than Insys Therapeutics and Theranos.

Last week, five former Insys executives, including founder John Kapoor, were found guilty of racketeering in pushing the company’s powerful opioid; jurors said they were horrified when they saw a music video, produced to pump up sales, featuring two Insys salesmen rapping about ramping up the dose of the painkiller. Meanwhile, ex-Theranos CEO Elizabeth Holmes and her former No. 2 Sunny Balwani are facing criminal charges for defrauding investors, patients, and physicians about their blood-testing technology; they’re expected to go to trial, perhaps next year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy